In addition to building a world-class facility to manufacture our precision engineered bacteriophage products, we have integrated the core capabilities needed to develop our drug products across the different routes of administration we deploy. Along the way, we have developed robust scientific and regulatory expertise in the development and manufacturing of viral vectors.
Employing high-throughput, multi-parallel prototyping bioreactors, Succor LLC tests multiple process parameters to establish upstream and downstream manufacturing processes that are reliable and cost-effective in meeting all critical quality attributes. Our bioreactors are designed for early process development and are directly scalable to our larger format bioreactors.
We provide GMP-compliant manufacturing for biologics, including recombinant proteins and advanced therapeutic products.
We design and optimize scalable manufacturing processes that transition efficiently from laboratory to commercial scale.
Our aseptic fill-finish capabilities support sterile drug product manufacturing with strict contamination control.
Analytical testing and batch release to ensure product quality and compliance.
